Characteristics of RCT versus real-world target populations
This analysis included 673 clinical trial participants (n = 570 X:BOT and n = 103 CHOICES), 139 NSDUH respondents (weighted to represent 661,650 people), 71,751 TEDS treatment episodes, and 1933 ROI participants. Table 